Answers are grounded in this paper and cite their sources.
Observational analysis of NVUGIB cases shows high rebleeding rates in peptic ulcer patients, indicating mortality and intervention needs.
Introduction: Nonvariceal upper gastrointestinal bleeding (NVUGIB) is life threatening condition. It is important to eludicate the risk factors for rebleeding, need of surgical involvement and mortality. Aims and methods: To evaluate outcomes of the NVUGIB cases in the University hospital in years 2008–2009, to assess the Rockall score (RS) as a prognostic tool for the rebleeding, surgery and mortality. We retrospectively analyzed the cases of the patients admitted to the University hospital due to nonvariceal UGIB in the years 2008 and 2009. There were 278 cases: 185 male, mean age (MA) – 56.9 ± 17 and 93 female, MA – 67.2 ± 17,p < 0.05. Results: The commonest reason for NVUGIB was peptic ulcer: in 202 (74.9%) patients. Active bleeding (Forrest IA, IB) manifested in 58 (20.9%). Endoscopic hemostasis was applied in 161 (57.9%) cases. All methods of endoscopic hemostasis were equal regarding the rebleeding, surgery or mortality rates. Rebleeding was observed in 37 (13.3%) cases. Surgical treatment was applied in 8 (2.9%) cases. Twenty-two (7.9%) patients died. Among conservatively treated – 20 (7.4%) patients died, among surgically treated patients – 2 (25%) died, p < 0.05. Among patients with active bleeding 11 (18.9%) patients died, among patients with inactive bleeding 11 (5%) patients died, p < 0.05. Baseline RS was 6.4 ± 27 in patients with rebleeding and 4.7 ± 2.2 in patients without rebleeding, p < 0.05. Baseline RS was 6.1 ± 2.9 in patients who needed surgery and 4.8 ± 2.3 in patients who were managed conservatively, p < 0.05. Baseline Rockall score of the patients who died was 7.9 ± 2.7, of the survived patients – 4.6 ± 2.2, p < 0.05. Conclusion: In our setting the most common reason for NVUGIB was peptic ulcer. The mortality was rather high – 7.9%. RS has a prognostic value to predict the rebleeding, the need of the surgical treatment and mortality.
No takes yet. Share an insight, caveat, or question.
Jonaitis et al. (2012) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: